Share This

Public company info - Ascletis Pharma Inc. , 01672.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Ascletis Pharma Inc., 01672.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -168,034 -171,340 -142,532 -138,099 -115,813 -190,328 -12,498
Net Cash Flow from Return on Investments & Servicing of Finance 25,424 24,285 57,486 63,758 -35,401 6,748 -64,377
　Interest Received 25,581 24,410 57,621 63,758 19,223 0 0
　Interest Paid -157 -125 -135 0 0 -317 0
　Dividend Received 0 0 0 0 3,191 7,065 99
　Dividend Paid 0 0 0 0 -57,815 0 -64,476
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 -7,728 0
Net Cash Flow from Investing Activities -1,297,387 -274,492 132,297 602,269 -820,662 -651,607 -37,732
　Additions to Fixed Assets -7,070 -4,968 -4,922 -18,885 -15,816 -15,298 -44,606
　Disposal of Fixed Assets 0 0 6 665 0 10 0
　Increase in Investments -482,000 -337,400 -95,070 -67,400 -229,000 -843,500 -5,610
　Decrease in Investments 479,322 334,684 75,708 0 372,000 706,110 14,000
　Net Cash Flow with Related Parties 0 0 0 0 0 549,679 395,199
　Others -1,287,639 -266,808 156,575 687,889 -947,846 -1,048,608 -396,715
Net Cash Flow before Financing Activities -1,439,997 -421,547 47,251 527,928 -971,876 -842,915 -114,607
Net Cash Flow from Financing Activities -1,262 -30,973 -21,535 -48,217 2,617,957 549,679 152,635
　New Loans 0 0 0 0 0 0 0
　Loans Repayment -2,223 -2,284 -1,934 -1,948 0 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 -249,954 0 0
　Equity Financing 961 0 0 0 2,970,782 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 549,679 395,199
　Others 0 -28,689 -19,601 -46,269 -102,871 0 -242,564
Increase(Decrease) in Cash & Cash Equivalents -1,441,259 -452,520 25,716 479,711 1,646,081 -293,236 38,028
Cash & Cash Equivalents at Beginning of Year 1,727,411 2,210,504 2,295,044 1,781,892 123,697 418,973 372,398
Net Cash Flow due to Change in Exchange Rate/Others 117,616 -30,573 -110,256 33,441 12,114 -2,040 8,547
Cash & Cash Equivalents at End of Year 403,768 1,727,411 2,210,504 2,295,044 1,781,892 123,697 418,973
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.